Valery Rusakov, a seasoned professional with over 12 years of experience in mergers and acquisitions and private equity and venture capital investments, has a background in the pharmaceutical, life sciences, and technology industries. He has honed his skills in project origination, negotiations, deal structuring, financial modeling, valuation, and due diligence of various projects, including buy-side and sell-side M&A transactions. With an educational background that includes a Master's in Economics and Strategic Corporate Finance and a Bachelor's in Economics and Corporate Finance, both from State University — Higher School of Economics, Valery has held various positions such as Corporate M&A, Public Services at Tata Consultancy Services; External Business Development at Cambridge Capital LLC; Vice President, M&A Advisory at Novus Capital; Senior Associate, M&A Advisory at BIC Securities; Chief Investment Analyst, Life Sciences Group at JSC RUSNANO; Analyst, Financial Advisory Services, Valuation Group at EY; and Experienced Auditor Assistant, Audit Department, TMT Group at Deloitte. Valery's understanding of the pharmaceutical, life sciences, and technology industries sets him apart as a professional worthy of recognition in the field of M&A.